Literature DB >> 17384961

Distinct effects of acute and chronic nicotine application on microvascular thrombus formation and endothelial function in male and female mice.

Nicole Lindenblatt1, Uwe Platz, Jörn Hameister, Ernst Klar, Michael D Menger, Brigitte Vollmar.   

Abstract

BACKGROUND AND AIMS: Cigarette smoking is linked to thromboembolic events; however, a relationship between nicotine exposition and thrombosis has not been established. Thus, we intended to study the effect of acute and chronic nicotine application in an in vivo mouse model.
MATERIALS AND METHODS: In microvessels of the dorsal skin fold chamber, light-dye-induced thrombus formation was analyzed using intravital fluorescence microscopy. Male and female C57BL/6J mice received nicotine chronically via the drinking water (100 microg/ml) for 8 weeks. An additional series of experiments was performed with acute iv nicotine treatment (3 mg/kg body weight).
RESULTS: No significant differences in microvascular thrombus formation were detected after chronic nicotine application in male and female animals when compared with controls. Accordingly, flow cytometric analysis did not show significant effects on platelet activity. Chronic nicotine treatment resulted in a significantly reduced endothelial activation in male, but not in female mice. In contrast, acute iv application of nicotine revealed significantly shorter thrombosis times in arterioles of female mice and a significantly increased endothelial P-selectin expression in mice of both genders.
CONCLUSION: Chronic nicotine application does not promote microvascular thrombus formation in mice of either gender, whereas acute high-dose iv administration caused a significant increase of arteriolar thrombosis in female animals probably via a synergistic effect of increased endothelial P-selectin expression and female hormone levels. A gender-dependency of acute nicotine action can be presumed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17384961     DOI: 10.1007/s00423-007-0173-6

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   2.895


  40 in total

Review 1.  Venous and arterial thrombosis during oral contraceptive use: risks and risk factors.

Authors:  Bea C Tanis; Frits R Rosendaal
Journal:  Semin Vasc Med       Date:  2003-02

2.  Flow-cytometric analysis of mouse platelet function.

Authors:  Bernhard Nieswandt; Valerie Schulte; Wolfgang Bergmeier
Journal:  Methods Mol Biol       Date:  2004

3.  The polysaccharide fucoidan inhibits microvascular thrombus formation independently from P- and L-selectin function in vivo.

Authors:  H Thorlacius; B Vollmar; U T Seyfert; D Vestweber; M D Menger
Journal:  Eur J Clin Invest       Date:  2000-09       Impact factor: 4.686

4.  Monocyte tissue factor expression is enhanced in women who smoke and use oral contraceptives.

Authors:  H Hölschermann; H M Terhalle; U Zakel; U Maus; B Parviz; H Tillmanns; W Haberbosch
Journal:  Thromb Haemost       Date:  1999-12       Impact factor: 5.249

5.  On-line volume flow rate and velocity profile measurement for blood in microvessels.

Authors:  M Baker; H Wayland
Journal:  Microvasc Res       Date:  1974-01       Impact factor: 3.514

6.  Oral administration of nicotine: its uptake and distribution after chronic administration to mice.

Authors:  P P Rowell; H E Hurst; C Marlowe; B D Bennett
Journal:  J Pharmacol Methods       Date:  1983-06

Review 7.  Pharmacokinetics and metabolism of nicotine.

Authors:  Piotr Tutka; Jerzy Mosiewicz; Marian Wielosz
Journal:  Pharmacol Rep       Date:  2005 Mar-Apr       Impact factor: 3.024

8.  A new model for quantitative in vivo microscopic analysis of thrombus formation and vascular recanalisation: the ear of the hairless (hr/hr) mouse.

Authors:  F Roesken; M Ruecker; B Vollmar; N Boeckel; E Morgenstern; M D Menger
Journal:  Thromb Haemost       Date:  1997-11       Impact factor: 5.249

9.  Cigarette smoking and progression of atherosclerosis: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  G Howard; L E Wagenknecht; G L Burke; A Diez-Roux; G W Evans; P McGovern; F J Nieto; G S Tell
Journal:  JAMA       Date:  1998-01-14       Impact factor: 56.272

10.  Mouse cremaster venules are predisposed to light/dye-induced thrombosis independent of wall shear rate, CD18, ICAM-1, or P-selectin.

Authors:  Rolando E Rumbaut; Jaspreet Kaur Randhawa; C Wayne Smith; Alan R Burns
Journal:  Microcirculation       Date:  2004 Apr-May       Impact factor: 2.628

View more
  7 in total

Review 1.  Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis.

Authors:  Sonal Singh; Yoon K Loke; John G Spangler; Curt D Furberg
Journal:  CMAJ       Date:  2011-07-04       Impact factor: 8.262

2.  Oral contraceptives and nicotine synergistically exacerbate cerebral ischemic injury in the female brain.

Authors:  Ami P Raval; Raquel Borges-Garcia; Francisca Diaz; Thomas J Sick; Helen Bramlett
Journal:  Transl Stroke Res       Date:  2013-02-13       Impact factor: 6.829

3.  Simultaneous nicotine and oral contraceptive exposure alters brain energy metabolism and exacerbates ischemic stroke injury in female rats.

Authors:  Francisca Diaz; Ami P Raval
Journal:  J Cereb Blood Flow Metab       Date:  2020-06-14       Impact factor: 6.200

Review 4.  Cardiovascular, carcinogenic and reproductive effects of nicotine exposure: A narrative review of the scientific literature.

Authors:  Leonie R Price; Javier Martinez
Journal:  F1000Res       Date:  2019-09-04

5.  The Marine-Derived Triterpenoid Frondoside A Inhibits Thrombus Formation.

Authors:  Emmanuel Ampofo; Thomas Später; Lisa Nalbach; Michael D Menger; Matthias W Laschke
Journal:  Mar Drugs       Date:  2020-02-14       Impact factor: 5.118

6.  Analysis of the influence of antithrombin on microvascular thrombosis: anti-inflammation is crucial for anticoagulation.

Authors:  Heiko Sorg; Julius O Hoffmann; Johannes N Hoffmann; Brigitte Vollmar
Journal:  Intensive Care Med Exp       Date:  2015-07-09

7.  The Marine-Derived Kinase Inhibitor Fascaplysin Exerts Anti-Thrombotic Activity.

Authors:  Emmanuel Ampofo; Thomas Später; Isabelle Müller; Hermann Eichler; Michael D Menger; Matthias W Laschke
Journal:  Mar Drugs       Date:  2015-11-09       Impact factor: 5.118

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.